These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 22579160

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 4. Comparison of treatment response in second-episode versus first-episode schizophrenia.
    Emsley R, Oosthuizen P, Koen L, Niehaus D, Martinez L.
    J Clin Psychopharmacol; 2013 Feb; 33(1):80-3. PubMed ID: 23277247
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment with long-acting risperidone in Korean patients with schizophrenia.
    Lee MS, Ko YH, Lee SH, Seo YJ, Kim SH, Joe SH, Han CS, Lee JH, Jung IK.
    Hum Psychopharmacol; 2006 Aug; 21(6):399-407. PubMed ID: 16915580
    [Abstract] [Full Text] [Related]

  • 11. Direct transition to long-acting risperidone--analysis of long-term efficacy.
    Kissling W, Heres S, Lloyd K, Sacchetti E, Bouhours P, Medori R, Llorca PM.
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):15-21. PubMed ID: 16144782
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
    Lasser RA, Bossie CA, Zhu Y, Gharabawi G, Eerdekens M, Davidson M.
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):898-905. PubMed ID: 15352149
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone.
    Martin SD, Libretto SE, Pratt DJ, Brewin JS, Huq ZU, Saleh BT.
    Curr Med Res Opin; 2003 Sep; 19(4):298-305. PubMed ID: 12841922
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-acting risperidone improves negative symptoms in stable psychotic patients.
    Curtis VA, Katsafouros K, Möller HJ, Medori R, Sacchetti E.
    J Psychopharmacol; 2008 May; 22(3):254-61. PubMed ID: 18308804
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.